BioCentury
ARTICLE | Distillery Therapeutics

Neurology

June 7, 2017 3:55 PM UTC

In vitro and mouse studies suggest inhibiting DNM1L could help treat AD. In primary rat hippocampal neurons exposed to β-amyloid oligomers, a DNM1L inhibitor tool compound decreased mitochondrial frag...

BCIQ Target Profiles

Dynamin 1-like (DNM1L) (DRP1)